Scarica l'app Stockscreener
5.85
1.74%
0.10
Dopo l'orario di chiusura:
5.75
-0.10
-1.71%
Satellos Bioscience Inc Borsa (MSLE) Ultime notizie
MSLE Q1 2026 Earnings: Smaller-than-Expected Loss as Positive EPS Surprise Drives Focus on Drug Development ProgressEarnings Cycle Report - newsline.com
Satellos Bioscience (MSLE) Slips 2.54% as Stock Tests Key Support Near $5.46Dividend Arbitrage - newsline.com
Why Satellos Bioscience Inc. stock is sliding today - Wealth Awesome
Satellos Bioscience Q1 2026 Earnings: Narrower-Than-Expected Loss as DMD Program AdvancesProfit Cycle Analysis - newsline.com
Why Satellos Bioscience Inc. stock is gaining today - Wealth Awesome
Satellos Bioscience Inc Company Profile & Introduction - Moomoo
Why Satellos Bioscience Inc. stock is rising today - Wealth Awesome
MSLE SEC FilingsSatellos Bioscience Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Satellos Bioscience Inc Financial Disclosures & Filings - TradingView
Insider Traders Lose US$134k As Satellos Bioscience Drops - simplywall.st
Satellos Bioscience (MSCL) Investor Relations, Earnings Summary & Outlook - Quartr
Leerink initiates Satellos Bioscience stock with Outperform rating - Investing.com
MSLE Q1 2026 Earnings: Narrower-Than-Expected Net Loss Highlights Cost Discipline Amid Pre-Revenue StatusForward EPS Estimate - newsline.com
Satellos Bioscience (MSLE) Surges 9%: Volume Spike Tests Key Resistance ZoneMESA MA - The Legal Advocate
Satellos to Participate in Upcoming Investor Conferences - Investing News Network
Satellos Bioscience to Highlight Neuromuscular Pipeline at June Investor Conferences - TipRanks
Satellos Bioscience (NASDAQ: MSLE) to present SAT-3247 program at June investor conferences - Stock Titan
Satellos Bioscience (MSLE) Surges 7% as Biotech Stock Breaks Above Key SupportBearish Pattern Stocks - newsline.com
Satellos Bioscience (MSLE) Slides 5.5% as Biotech Sector Headwinds Weigh on SentimentHidden Order - Newser
Satellos Bioscience Q1 2026 Earnings: Narrower Loss Reported, Stock Slips on Lack of Revenue Progress - Newser
Satellos Bioscience Inc. (MSLE) Q1 2026 Earnings: Narrower-Than-Expected Loss Marks Progress Amid Pre-Revenue StageCEO Earnings Statement - Newser
CCORF Initiates Satellos Bioscience(MSLE.US) With Buy Rating, Announces Target Price $13.81 - Moomoo
Satellos Bioscience Price Target Maintained With a $11.00/Share by HC Wainwright & Co. - Moomoo
Satellos Bioscience Sets June 17, 2026 Virtual Annual Shareholder Meeting - TipRanks
Virtual AGM, board elections and pay disclosure at Satellos Bioscience (NASDAQ: MSLE) - Stock Titan
Satellos Bioscience (MSLE) Stock Analysis: Flat at $7.15, What's Next 2026-05-19Overnight Profile - The Legal Advocate
MSLE Reiterated by HC Wainwright & Co. -- Price Target Maintained at $11 - GuruFocus
Satellos Bioscience (MSLE) Q1 2026 Earnings: EPS $-0.53 Beats EstimatesHigh Attention Stocks - newser.com
Satellos Bioscience (TSX:MSCL) Extends Cash Runway Confidence - Kalkine Media
H.C. Wainwright Maintains Satellos Bioscience(MSLE.US) With Buy Rating, Maintains Target Price $11 - Moomoo
We're Not Very Worried About Satellos Bioscience's (TSE:MSCL) Cash Burn Rate - Yahoo Finance
Stocks In Play - Baystreet.ca
Satellos Bioscience (MSLE) insiders report 1.14M shares, 7.35% stake - Stock Titan
Positive Developments for Satellos (MSLE) in Q1 2026 - GuruFocus
Satellos Bioscience Inc. - Baystreet.ca
Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress - Investing News Network
Satellos Bioscience : First Quarter 2026 Management’s Discussion Analysis - marketscreener.com
Satellos Bioscience Posts Wider Q1 2026 Loss but Strengthens Balance Sheet - TipRanks
Satellos Bioscience: Q1 Earnings Snapshot - marketscreener.com
Satellos Bioscience (NASDAQ: MSLE) raises $57M and advances Duchenne trials - Stock Titan
MSLE Price Today: Satellos Bioscience Inc. Stock Price, Quote & Chart | MEXC - MEXC
Qiming reports 1.725M Satellos shares; MSLE ownership disclosure - Stock Titan
Number of shareholders of Satellos Bioscience Inc. – BOATS:MSLE - TradingView
What Satellos Bioscience (MSLE) is doing that separates it from the herd (+0.13%) 2026-05-11Alpha Picks - newser.com
Why Satellos Bioscience (MSLE) could be the anchor your portfolio needs (Smart Money Flows) 2026-05-08Real-time Trade Ideas - Newser
Certain Stock Options of Satellos Bioscience Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2026. - marketscreener.com
Certain Pre-Funded Warrants of Satellos Bioscience Inc. are subject to a Lock-Up Agreement Ending on 7-MAY-2026. - marketscreener.com
Satellos Bioscience Inc expected to post a loss of 69 cents a shareEarnings Preview - TradingView
MSLE Stock Price, Quote & Chart | SATELLOS BIOSCIENCE INC (NASDAQ:MSLE) - ChartMill
Guggenheim Initiates Satellos Bioscience(MSLE.US) With Buy Rating, Announces Target Price $23 - Moomoo
Guggenheim Initiates Satellos Bioscience at Buy With CA$31.43 Price Target - Moomoo
Satellos launches public offering, applies for Nasdaq listing - MSN
2.60%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):